Connect to other sites within the UBM Medica Network
Adjuvant Chemotherapy Improves Survival in Bladder Cancer
Patients with bladder cancer derived an overall survival benefit from the use of adjuvant chemotherapy compared with observation.
Urine Test Detects Bladder Cancer Recurrence
A urine test (CellDetect) was able to detect disease recurrence in bladder cancer patients, with a reported sensitivity of 84.4% and specificity of 82.7%.
Bladder Cancer: Mortality, Morbidity, and QoL After Treatment
While observation may be appropriate for select cases where prognosis is poor, rates of non-treatment are unacceptably high in muscle-invasive bladder cancer.
Bladder Cancer Survival Similar With Laparoscopic, Open Surgery
Long-term survival rates of patients after laparoscopic surgery for bladder cancer are similar to rates achieved with standard open surgery.
Million-Person Study Shows No Link Between Pioglitazone and Bladder Cancer
An extremely large database study across more than one million people found no increased risk of bladder cancer with the diabetes drug pioglitazone.
Anti-PD-L1 Drug Shows Promise in Bladder Cancer
A large phase I study showed that the PD-L1 antibody known as MPDL3280A has promising activity in patients with urothelial bladder cancer.
Smoking May Increase Risk of Second Primary Cancer
Cancer survivors are at an increased risk for developing a second smoking-associated cancer if they smoked cigarettes prior to their first cancer diagnosis.
By clicking Accept, you agree to become a member of the UBM Medica Community.